Literature DB >> 35809

Chlordiazepoxide loses its anxiolytic action with long-term treatment.

S V Vellucci, S E File.   

Abstract

The biochemical and behavioural effects of acute, 5, 15 and 25 days treatment with chlordiazepoxide (CDP, 5 mg/kg) were examined in the rat. After 5 days of drug treatment, 5-hydroxytryptamine (5HT) levels in the midbrain, hypothalamus and cortex were significantly higher than those of the corresponding controls, and the level of 5-hydroxyindoleacetic acid (5HIAA) was significantly lower, indicating reduced turnover. After 15 days of drug treatment, 5HIAA levels were significantly elevated, compared with the controls, possibly indicating that CDP was blocking the transport of 5HIAA from the brain. This effect appears to be independent of the reduced turnover. After 25 days of drug treatment there were no significant differences compared with the controls. There were no marked changes in noradrenaline and dopamine in any of the areas investigated. It appears that the reduction in 5HT turnover is linked to the anxiolytic effects of CDP; the latter were found after 5 days of drug treatment, but not after 15 or 25 days, using the social interaction test of anxiety.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35809     DOI: 10.1007/bf00426036

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.

Authors:  R A Agarwal; Y D Lapierre; R B Rastogi; R L Singhal
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Effects of ethanol and chlordiazepoxide on social interaction in rats [proceedings].

Authors:  S E File; J Hyde; M Pool
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

3.  Benzodiazepines--the opium of the masses?

Authors:  M Lader
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

4.  Diazepam increases 5-hydroxyindole concentrations in rat brain and spinal cord.

Authors:  J D Fernstrom; H Shabshelowitz; D V Faller
Journal:  Life Sci       Date:  1974-11-01       Impact factor: 5.037

5.  Effects of benzoctamine and chlordiazepoxide on turnover and uptake of 5-hydroxytryptamine in the brain.

Authors:  W Lippmann; T A Pugsley
Journal:  Br J Pharmacol       Date:  1974-08       Impact factor: 8.739

6.  The effect of minor tranquilizers on stress-induced increases in rat plasma corticosteroids.

Authors:  R A Lahti; C Barsuhn
Journal:  Psychopharmacologia       Date:  1974-02-27

7.  The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain.

Authors:  K M Taylor; R Laverty
Journal:  Eur J Pharmacol       Date:  1969-12       Impact factor: 4.432

8.  Minor tranquillizers, stress and central catecholamine neurons.

Authors:  H Corrodi; K Fuxe; P Lidbrink; L Olson
Journal:  Brain Res       Date:  1971-06-04       Impact factor: 3.252

9.  Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.

Authors:  C D Wise; B D Berger; L Stein
Journal:  Science       Date:  1972-07-14       Impact factor: 47.728

10.  Can social interaction be used to measure anxiety?

Authors:  S E File; J R Hyde
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

View more
  19 in total

1.  Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.

Authors:  S E File; J Dingemanse; H L Friedman; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Facilitation of stimulatory effect of chlordiazepoxide-amphetamine combination by subacute administration of chlordiazepoxide in mice.

Authors:  M Sansone; P Renzi; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

Authors:  S E File; P S Mabbutt; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Blockade of hoarding in rats by diazepam: an analysis of the anxiety and object value hypotheses of hoarding.

Authors:  R K McNamara; I Q Whishaw
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.

Authors:  K A Miczek; E M Weerts; J A Vivian; H M Barros
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

6.  A neuroendocrine approach to benzodiazepine tolerance and dependence.

Authors:  H Petursson; E Shur; S Checkley; A Slade; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

7.  Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity.

Authors:  D N Stephens; H H Schneider
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.

Authors:  P Chopin; M B Assié; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

10.  Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors.

Authors:  S Ishihara; M Hiramatsu; T Kameyama; T Nabeshima
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.